CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

September 17, 2021
Open Access

A Mathematical Modeling Approach for Targeted Radionuclide and Chimeric Antigen Receptor-T Cell Combination Therapy
Vikram AdhikarlaRussell C. Rockne
September 17, 2021

Response to "CAR T-Cell Therapy: Updates in Nursing Management".

Clinical Journal of Oncology Nursing
Pat Groff, Brittney Baer
September 17, 2021

Pushing the boundaries of organs before it's too late: pre-emptive regeneration.

Transplant International : Official Journal of the European Society for Organ Transplantation
Mehdi Maanaoui, Julie Kerr-Conte
September 17, 2021

Chimeric antigen receptor T-cells in New Zealand: challenges and opportunities.

The New Zealand Medical Journal
Robert WeinkoveGiulia Giunti
September 17, 2021
Open Access

Homogeneously high expression of CD32b makes it a potential target for CAR-T therapy for chronic lymphocytic leukemia.

Journal of Hematology & Oncology
Guoling WangXiaoming Feng
September 16, 2021
Open Access

High Seroconversion Rates Amongst Black and Hispanics With Hematologic Malignancies after SARS-CoV-2 Vaccination

MedRxiv : the Preprint Server for Health Sciences
L. C. ShapiroR Alejandro Sica
September 16, 2021

Cancer immunotherapy: Recent advances and challenges.

Journal of Cancer Research and Therapeutics
Ruby DharSubhradip Karmakar
September 16, 2021
Open Access

Combination of AAV-CCL19 and GPC3 CAR-T Cells in the Treatment of Hepatocellular Carcinoma.

Journal of Immunology Research
Min Meng, Yi-Chen Wu
September 16, 2021

Immunotherapy of Multiple Myeloma: Promise and Challenges.

ImmunoTargets and Therapy
Hanley N Abramson
September 16, 2021

An engineered IL-2 partial agonist promotes CD8+ T cell stemness.

Fei MoWarren J Leonard
September 16, 2021

The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Shwetha H ManjunathIma Paydar
September 15, 2021
Open Access

Naive and in vitro-activated primary mouse CD8+ T cells retain in vivo immune responsiveness after electroporation-based CRISPR/Cas9 genetic engineering

BioRxiv : the Preprint Server for Biology
P. PfenningerJun Abe
September 16, 2021

Characterization of HLH-Like Manifestations as a CRS Variant in Patients Receiving CD22 CAR T-Cells.

Daniel A LichtensteinNirali N Shah
September 16, 2021

Adoptive T-cell immunotherapy in digestive tract malignancies: Current challenges and future perspectives.

Cancer Treatment Reviews
Barbara MandrianiCamillo Porta
September 16, 2021

[New treatment for patients with therapy-resistant lymphoma: CD19-targeted chimeric antigen receptor (CAR) T-cell therapy].

Nederlands tijdschrift voor geneeskunde
Jaap A van DoesumTom van Meerten
September 16, 2021

Chimeric antigen receptor-T cells immunotherapy for targeting breast cancer.

Research in Pharmaceutical Sciences
Ilnaz Rahimmanesh, Hossein Khanahmad

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

© 2021 Meta ULC. All rights reserved